Cargando…
Analytical and Clinical Validity Study of FirstStepDx PLUS: A Chromosomal Microarray Optimized for Patients with Neurodevelopmental Conditions
INTRODUCTION: Chromosomal microarray analysis (CMA) is recognized as the first-tier test in the genetic evaluation of children with developmental delays, intellectual disabilities, congenital anomalies and autism spectrum disorders of unknown etiology. ARRAY DESIGN: To optimize detection of clinical...
Autores principales: | Hensel, Charles, Vanzo, Rena, Martin, Megan, Dixon, Sean, Lambert, Christophe, Levy, Brynn, Nelson, Lesa, Peiffer, Andy, Ho, Karen S., Rushton, Patricia, Serrano, Moises, South, Sarah, Ward, Kenneth, Wassman, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346028/ https://www.ncbi.nlm.nih.gov/pubmed/28357155 http://dx.doi.org/10.1371/currents.eogt.7d92ce775800ef3fbc72e3840fb1bc22 |
Ejemplares similares
-
Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders
por: Ho, Karen S., et al.
Publicado: (2016) -
Use of Oncotype DX in Women with Node-Positive Breast Cancer
por: Ishibe, Naoko, et al.
Publicado: (2011) -
DecisionDx-GBM Gene Expression Assay for Prognostic Testing in Glioblastoma Multiform
por: Allingham-Hawkins, Diane, et al.
Publicado: (2010) -
Oncotype DX tumor gene expression profiling in stage II colon cancer: Application: Prognostic, risk prediction
por: Webber, Elizabeth M., et al.
Publicado: (2010) -
Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis
por: Prasad, Aparna, et al.
Publicado: (2018)